Abstract
Oral leukoplakia is a relatively common lesion with a significant proportion of cases changing into cancer. Since most leukoplakias are asymptomatic, the primary objective of treatment must aim at the prevention of such malignant transformation. The main objectives of the study are to observe (1) the efficacy, safety and acceptability of the neodymium:yttrium aluminum garnet (Nd:YAG) laser in the management of oral leukoplakia; (2) the nature of postoperative complications, if any, associated with laser ablation, and (3) the 3-year prognosis of oral leukoplakia treated with laser. Twenty-eight patients with histologically proven leukoplakia were treated with Nd:YAG laser. From this study, we observed that the patients treated with Nd:YAG laser had only mild to moderate pain, swelling and restricted mouth opening, which peaked between 72 h and 1 week. In a majority of the patients the healing was prolonged, to a maximum of 5 weeks, and there was no clinical evidence of scarring in 26 out of 28 cases. In this study we achieved a cure rate of 92.86% in a 6-month period. Further follow-up after 3 years yielded almost the same result, except that one patient was not available for follow-up. We concluded that Nd:YAG laser is an effective device in the management of oral leukoplakia, which is one of the major pre-cancerous lesions in our country.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Axell T, Pindborg JJ, Smith CJ, van der Waal I (1996) Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25:49–54
Chiesa F, Tradati N, Sala L, Costa L, Podrecca S, Boracchi P, Bandieramonte G, Mauri M, Molinari R (1990) Follow-up of oral leukoplakias after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 116:177–180
Gupta PC (1989) Leukoplakia and incidence of oral cancer. J Oral Pathol Med 18:17
Lind PO (1987) Malignant transformation in oral leukoplakia. Scand J Dent Res 95:449–455
Mishra M, Mohanty J, Sengupta S, Tripathy S (2005) Epidemiological and clinicopathological study of oral leukoplakia. Indian J Dermatol Venereol Leprol 71:161–165
Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu X-C, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM (2000) Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6:1702–1710
Silverman S Jr, Bhargava K, Mani J, Smith LW, Maloawalla AM (1976) Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers in Gujarat, India. Cancer 38:1790–1795
Epstein JB, Gorsky M (2000) Topical application of vitamin A to oral leukoplakia: a clinical case series. Cancer 86:921–927
Girod SC, Pfahl M (1996) Retinoid actions and implications for prevention and therapy of oral cancer. Int J Oral Maxillofac Surg 25:69–73
Toma S, Mangiante PE, Margarino G, Nicolo G, Palumbo R (1992) Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia. Eur J Cancer B Oral Oncol 28B:121–123
Garewal H (1994) Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia. Eur J Cancer Prev 3:101–107
Mincer HH, Coleman SA, Hopkins KP (1972) Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol 33:389–399
Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Fukuda H (2001) Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 30:49–53
Chu FWK, Silverman SJ, Dedo HH (1988) CO2 laser treatment. of oral leukoplakia. Laryngoscope 98:125–130
Ishii J, Fujita K, Munemoto S, Komori T (2004) Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features. J Clin Laser Med Surg 22:27–33
Guerry TL, Silverman S Jr, Dedo HH (1986) Carbon dioxide laser resection of superficial oral carcinoma: indications, technique, and results. Ann Otol Rhinol Laryngol 95:547–555
Patel DD (1991) Medilas Nd:YAG laser in oral cavity cancer. J Clin Laser Med Surg. 9:475–477
Panje WR, Scher N, Karnell M (1989) Transoral carbon dioxide laser ablation for cancer, tumors, and other diseases. Arch Otolaryngol Head Neck Surg 115:681–688
White JM, Chaudhry SI, Kudler JJ, Sekandari N, Schoelch ML, Silverman S Jr (1998) Nd: YAG and CO2 laser therapy of oral mucosal lesions. J Clin Laser Med Surg 16:299–304
Schoelch ML, Sekandari N, Regezi JA, Silverman S Jr (1999) Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 109:949–953
Roodenburg JLN, Panders AK, Vermey A (1991) Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 71:670–674
Ariyawardana A, Panagoda GJ, Fernando HN, Ellepola ANB, Tilakaratne WM, Samaranayake LP (2007) Oral submucous fibrosis and oral yeast carriage—a case control study in Sri Lankan patients. Mycoses 50:116–120
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vivek, V., Jayasree, R.S., Balan, A. et al. Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery. Lasers Med Sci 23, 375–379 (2008). https://doi.org/10.1007/s10103-007-0500-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-007-0500-8